feed,title,long_url,short_url
Benzinga,"Goldman Scrutinizes Hits, Misses, And Growth Trajectory Concerns For Eli Lilly And Its Its Obesity and Diabetes Drugs",https://benzinga.com/analyst-ratings/analyst-color/24/04/38531968/goldman-scrutinizes-hits-misses-and-growth-trajectory-concerns-for-eli-lilly-and-it,https://da.gd/GbLPA3
Benzinga,"Tesla Set to Boost Revenue and Margins with China Breakthrough, Analyst Predicts",https://benzinga.com/news/24/04/38531925/tesla-set-to-boost-revenue-and-margins-with-china-breakthrough-analyst-predicts,https://da.gd/H4m1SG
